Previous slide
Next slide

Welcome to the EAASM website

Contact us to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary.

The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM’s activities and achievements click here

On this website, you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.

EAASM Newsletters

Summer 2023
Summer Newsletter 2023

Latest News

Articles from July 2007

Fake medicines being sold in Indonesia  Police in central Jakarta, Indonesia conducted surveillance and a test purchase of prescription and non-prescription medicines being sold over

Read More ›

Articles from June 2007

Plavix®: Class 1 medicines recall The MHRA in conjunction with the EMEA, with assistance from Waymade plc, are recalling parallel distributed stock of batches 3103/1

Read More ›

Articles from May 2007

Plavix®: Class 1 medicines recall  The MHRA in conjunction with the EMEA, with assistance from sanofi-aventis and Bristol-Myers Squibb, are recalling parallel distributed stock of

Read More ›